Amyloid-Journal of Protein Folding Disorders

Papers
(The H4-Index of Amyloid-Journal of Protein Folding Disorders is 15. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-10-01 to 2024-10-01.)
ArticleCitations
Amyloid nomenclature 2020: update and recommendations by the International Society of Amyloidosis (ISA) nomenclature committee282
Amyloid nomenclature 2022: update, novel proteins, and recommendations by the International Society of Amyloidosis (ISA) Nomenclature Committee150
Efficacy and safety of vutrisiran for patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy: a randomized clinical trial131
Guidelines and new directions in the therapy and monitoring of ATTRv amyloidosis71
Clarification on the definition of complete haematologic response in light-chain (AL) amyloidosis60
Guidelines for high dose chemotherapy and stem cell transplantation for systemic AL amyloidosis: EHA-ISA working group guidelines56
Guidelines for non-transplant chemotherapy for treatment of systemic AL amyloidosis: EHA-ISA working group35
Tissue biopsy for the diagnosis of amyloidosis: experience from some centres29
Association between spinal stenosis and wild-type ATTR amyloidosis27
Protease resistance of ex vivo amyloid fibrils implies the proteolytic selection of disease-associated fibril morphologies25
New data on the genetic profile and penetrance of hereditary Val30Met transthyretin amyloidosis in Sweden20
Amyloidosis from the patient perspective: the French daily impact of amyloidosis study19
Diflunisal treatment is associated with improved survival for patients with early stage wild-type transthyretin (ATTR) amyloid cardiomyopathy: the Boston University Amyloidosis Center experience18
A natural history analysis of asymptomatic TTR gene carriers as they develop symptomatic transthyretin amyloidosis in the Transthyretin Amyloidosis Outcomes Survey (THAOS)15
Cerebral amyloid angiopathy in a 51-year-old patient with embolization by dura mater extract and surgery for nasopharyngeal angiofibroma at age 1715
0.20426607131958